Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Vancomycin Market Growth 2022-2028

  • LP 4832686
  • 121 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Vancomycin will have significant change from previous year. According to our (LP Information) latest study, the global Vancomycin market size is USD million in 2022 from USD 326.7 million in 2021, with a change of % between 2021 and 2022. The global Vancomycin market size will reach USD 468 million in 2028, growing at a CAGR of 5.3% over the analysis period.

The United States Vancomycin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vancomycin market, reaching US$ million by the year 2028. As for the Europe Vancomycin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Vancomycin players cover Pfizer, Eli Lilly and Company, CJ CheilJedang, and Xellia Pharmaceuticals ApS, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Vancomycin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Daptomycin

Linezolid

Quinupristin

Ampicillin

Chloramphenicol

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Sepsis

Lung Infection

Skin Soft Tissue Infection

Colitis & Intestinal Inflammation

To Prevent Infection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

Eli Lilly and Company

CJ CheilJedang

Xellia Pharmaceuticals ApS

VIANEX

Alchemia Limited

Alvogen

Aphios Corporation

Cellceutix Corporation

Enanta Pharmaceuticals

Helix BioMedix

LegoChem Biosciences

Lytix Biopharma

MGB Biopharma Limited

Microbiotix.

MicuRx Pharmaceuticals

Nabriva Therapeutics

NovaBay Pharmaceuticals

NovoBiotic Pharmaceuticals

Oragenics

Sealife Pharma

Taiwan Zhengde Pharmaceutical

Zhejiang Pharmaceutical

Zhejiang Haizheng Pharmaceutical

North China Pharmaceutical

Shenwei Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vancomycin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vancomycin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vancomycin by Country/Region, 2017, 2022 & 2028

2.2 Vancomycin Segment by Type

2.2.1 Daptomycin

2.2.2 Linezolid

2.2.3 Quinupristin

2.2.4 Ampicillin

2.2.5 Chloramphenicol

2.2.6 Others

2.3 Vancomycin Sales by Type

2.3.1 Global Vancomycin Sales Market Share by Type (2017-2022)

2.3.2 Global Vancomycin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vancomycin Sale Price by Type (2017-2022)

2.4 Vancomycin Segment by Application

2.4.1 Sepsis

2.4.2 Lung Infection

2.4.3 Skin Soft Tissue Infection

2.4.4 Colitis & Intestinal Inflammation

2.4.5 To Prevent Infection

2.5 Vancomycin Sales by Application

2.5.1 Global Vancomycin Sale Market Share by Application (2017-2022)

2.5.2 Global Vancomycin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vancomycin Sale Price by Application (2017-2022)

3 Global Vancomycin by Company

3.1 Global Vancomycin Breakdown Data by Company

3.1.1 Global Vancomycin Annual Sales by Company (2020-2022)

3.1.2 Global Vancomycin Sales Market Share by Company (2020-2022)

3.2 Global Vancomycin Annual Revenue by Company (2020-2022)

3.2.1 Global Vancomycin Revenue by Company (2020-2022)

3.2.2 Global Vancomycin Revenue Market Share by Company (2020-2022)

3.3 Global Vancomycin Sale Price by Company

3.4 Key Manufacturers Vancomycin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vancomycin Product Location Distribution

3.4.2 Players Vancomycin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vancomycin by Geographic Region

4.1 World Historic Vancomycin Market Size by Geographic Region (2017-2022)

4.1.1 Global Vancomycin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vancomycin Annual Revenue by Geographic Region

4.2 World Historic Vancomycin Market Size by Country/Region (2017-2022)

4.2.1 Global Vancomycin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vancomycin Annual Revenue by Country/Region

4.3 Americas Vancomycin Sales Growth

4.4 APAC Vancomycin Sales Growth

4.5 Europe Vancomycin Sales Growth

4.6 Middle East & Africa Vancomycin Sales Growth

5 Americas

5.1 Americas Vancomycin Sales by Country

5.1.1 Americas Vancomycin Sales by Country (2017-2022)

5.1.2 Americas Vancomycin Revenue by Country (2017-2022)

5.2 Americas Vancomycin Sales by Type

5.3 Americas Vancomycin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vancomycin Sales by Region

6.1.1 APAC Vancomycin Sales by Region (2017-2022)

6.1.2 APAC Vancomycin Revenue by Region (2017-2022)

6.2 APAC Vancomycin Sales by Type

6.3 APAC Vancomycin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vancomycin by Country

7.1.1 Europe Vancomycin Sales by Country (2017-2022)

7.1.2 Europe Vancomycin Revenue by Country (2017-2022)

7.2 Europe Vancomycin Sales by Type

7.3 Europe Vancomycin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vancomycin by Country

8.1.1 Middle East & Africa Vancomycin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vancomycin Revenue by Country (2017-2022)

8.2 Middle East & Africa Vancomycin Sales by Type

8.3 Middle East & Africa Vancomycin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vancomycin

10.3 Manufacturing Process Analysis of Vancomycin

10.4 Industry Chain Structure of Vancomycin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vancomycin Distributors

11.3 Vancomycin Customer

12 World Forecast Review for Vancomycin by Geographic Region

12.1 Global Vancomycin Market Size Forecast by Region

12.1.1 Global Vancomycin Forecast by Region (2023-2028)

12.1.2 Global Vancomycin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vancomycin Forecast by Type

12.7 Global Vancomycin Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Vancomycin Product Offered

13.1.3 Pfizer Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Eli Lilly and Company

13.2.1 Eli Lilly and Company Company Information

13.2.2 Eli Lilly and Company Vancomycin Product Offered

13.2.3 Eli Lilly and Company Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Eli Lilly and Company Main Business Overview

13.2.5 Eli Lilly and Company Latest Developments

13.3 CJ CheilJedang

13.3.1 CJ CheilJedang Company Information

13.3.2 CJ CheilJedang Vancomycin Product Offered

13.3.3 CJ CheilJedang Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CJ CheilJedang Main Business Overview

13.3.5 CJ CheilJedang Latest Developments

13.4 Xellia Pharmaceuticals ApS

13.4.1 Xellia Pharmaceuticals ApS Company Information

13.4.2 Xellia Pharmaceuticals ApS Vancomycin Product Offered

13.4.3 Xellia Pharmaceuticals ApS Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Xellia Pharmaceuticals ApS Main Business Overview

13.4.5 Xellia Pharmaceuticals ApS Latest Developments

13.5 VIANEX

13.5.1 VIANEX Company Information

13.5.2 VIANEX Vancomycin Product Offered

13.5.3 VIANEX Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 VIANEX Main Business Overview

13.5.5 VIANEX Latest Developments

13.6 Alchemia Limited

13.6.1 Alchemia Limited Company Information

13.6.2 Alchemia Limited Vancomycin Product Offered

13.6.3 Alchemia Limited Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Alchemia Limited Main Business Overview

13.6.5 Alchemia Limited Latest Developments

13.7 Alvogen

13.7.1 Alvogen Company Information

13.7.2 Alvogen Vancomycin Product Offered

13.7.3 Alvogen Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Alvogen Main Business Overview

13.7.5 Alvogen Latest Developments

13.8 Aphios Corporation

13.8.1 Aphios Corporation Company Information

13.8.2 Aphios Corporation Vancomycin Product Offered

13.8.3 Aphios Corporation Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Aphios Corporation Main Business Overview

13.8.5 Aphios Corporation Latest Developments

13.9 Cellceutix Corporation

13.9.1 Cellceutix Corporation Company Information

13.9.2 Cellceutix Corporation Vancomycin Product Offered

13.9.3 Cellceutix Corporation Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Cellceutix Corporation Main Business Overview

13.9.5 Cellceutix Corporation Latest Developments

13.10 Enanta Pharmaceuticals

13.10.1 Enanta Pharmaceuticals Company Information

13.10.2 Enanta Pharmaceuticals Vancomycin Product Offered

13.10.3 Enanta Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Enanta Pharmaceuticals Main Business Overview

13.10.5 Enanta Pharmaceuticals Latest Developments

13.11 Helix BioMedix

13.11.1 Helix BioMedix Company Information

13.11.2 Helix BioMedix Vancomycin Product Offered

13.11.3 Helix BioMedix Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Helix BioMedix Main Business Overview

13.11.5 Helix BioMedix Latest Developments

13.12 LegoChem Biosciences

13.12.1 LegoChem Biosciences Company Information

13.12.2 LegoChem Biosciences Vancomycin Product Offered

13.12.3 LegoChem Biosciences Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 LegoChem Biosciences Main Business Overview

13.12.5 LegoChem Biosciences Latest Developments

13.13 Lytix Biopharma

13.13.1 Lytix Biopharma Company Information

13.13.2 Lytix Biopharma Vancomycin Product Offered

13.13.3 Lytix Biopharma Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Lytix Biopharma Main Business Overview

13.13.5 Lytix Biopharma Latest Developments

13.14 MGB Biopharma Limited

13.14.1 MGB Biopharma Limited Company Information

13.14.2 MGB Biopharma Limited Vancomycin Product Offered

13.14.3 MGB Biopharma Limited Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 MGB Biopharma Limited Main Business Overview

13.14.5 MGB Biopharma Limited Latest Developments

13.15 Microbiotix.

13.15.1 Microbiotix. Company Information

13.15.2 Microbiotix. Vancomycin Product Offered

13.15.3 Microbiotix. Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Microbiotix. Main Business Overview

13.15.5 Microbiotix. Latest Developments

13.16 MicuRx Pharmaceuticals

13.16.1 MicuRx Pharmaceuticals Company Information

13.16.2 MicuRx Pharmaceuticals Vancomycin Product Offered

13.16.3 MicuRx Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 MicuRx Pharmaceuticals Main Business Overview

13.16.5 MicuRx Pharmaceuticals Latest Developments

13.17 Nabriva Therapeutics

13.17.1 Nabriva Therapeutics Company Information

13.17.2 Nabriva Therapeutics Vancomycin Product Offered

13.17.3 Nabriva Therapeutics Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Nabriva Therapeutics Main Business Overview

13.17.5 Nabriva Therapeutics Latest Developments

13.18 NovaBay Pharmaceuticals

13.18.1 NovaBay Pharmaceuticals Company Information

13.18.2 NovaBay Pharmaceuticals Vancomycin Product Offered

13.18.3 NovaBay Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 NovaBay Pharmaceuticals Main Business Overview

13.18.5 NovaBay Pharmaceuticals Latest Developments

13.19 NovoBiotic Pharmaceuticals

13.19.1 NovoBiotic Pharmaceuticals Company Information

13.19.2 NovoBiotic Pharmaceuticals Vancomycin Product Offered

13.19.3 NovoBiotic Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 NovoBiotic Pharmaceuticals Main Business Overview

13.19.5 NovoBiotic Pharmaceuticals Latest Developments

13.20 Oragenics

13.20.1 Oragenics Company Information

13.20.2 Oragenics Vancomycin Product Offered

13.20.3 Oragenics Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Oragenics Main Business Overview

13.20.5 Oragenics Latest Developments

13.21 Sealife Pharma

13.21.1 Sealife Pharma Company Information

13.21.2 Sealife Pharma Vancomycin Product Offered

13.21.3 Sealife Pharma Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Sealife Pharma Main Business Overview

13.21.5 Sealife Pharma Latest Developments

13.22 Taiwan Zhengde Pharmaceutical

13.22.1 Taiwan Zhengde Pharmaceutical Company Information

13.22.2 Taiwan Zhengde Pharmaceutical Vancomycin Product Offered

13.22.3 Taiwan Zhengde Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Taiwan Zhengde Pharmaceutical Main Business Overview

13.22.5 Taiwan Zhengde Pharmaceutical Latest Developments

13.23 Zhejiang Pharmaceutical

13.23.1 Zhejiang Pharmaceutical Company Information

13.23.2 Zhejiang Pharmaceutical Vancomycin Product Offered

13.23.3 Zhejiang Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Zhejiang Pharmaceutical Main Business Overview

13.23.5 Zhejiang Pharmaceutical Latest Developments

13.24 Zhejiang Haizheng Pharmaceutical

13.24.1 Zhejiang Haizheng Pharmaceutical Company Information

13.24.2 Zhejiang Haizheng Pharmaceutical Vancomycin Product Offered

13.24.3 Zhejiang Haizheng Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Zhejiang Haizheng Pharmaceutical Main Business Overview

13.24.5 Zhejiang Haizheng Pharmaceutical Latest Developments

13.25 North China Pharmaceutical

13.25.1 North China Pharmaceutical Company Information

13.25.2 North China Pharmaceutical Vancomycin Product Offered

13.25.3 North China Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 North China Pharmaceutical Main Business Overview

13.25.5 North China Pharmaceutical Latest Developments

13.26 Shenwei Pharmaceutical

13.26.1 Shenwei Pharmaceutical Company Information

13.26.2 Shenwei Pharmaceutical Vancomycin Product Offered

13.26.3 Shenwei Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Shenwei Pharmaceutical Main Business Overview

13.26.5 Shenwei Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Vancomycin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vancomycin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Daptomycin

Table 4. Major Players of Linezolid

Table 5. Major Players of Quinupristin

Table 6. Major Players of Ampicillin

Table 7. Major Players of Chloramphenicol

Table 8. Major Players of Others

Table 9. Global Vancomycin Sales by Type (2017-2022) & (KG)

Table 10. Global Vancomycin Sales Market Share by Type (2017-2022)

Table 11. Global Vancomycin Revenue by Type (2017-2022) & ($ million)

Table 12. Global Vancomycin Revenue Market Share by Type (2017-2022)

Table 13. Global Vancomycin Sale Price by Type (2017-2022) & (US$/G)

Table 14. Global Vancomycin Sales by Application (2017-2022) & (KG)

Table 15. Global Vancomycin Sales Market Share by Application (2017-2022)

Table 16. Global Vancomycin Revenue by Application (2017-2022)

Table 17. Global Vancomycin Revenue Market Share by Application (2017-2022)

Table 18. Global Vancomycin Sale Price by Application (2017-2022) & (US$/G)

Table 19. Global Vancomycin Sales by Company (2020-2022) & (KG)

Table 20. Global Vancomycin Sales Market Share by Company (2020-2022)

Table 21. Global Vancomycin Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Vancomycin Revenue Market Share by Company (2020-2022)

Table 23. Global Vancomycin Sale Price by Company (2020-2022) & (US$/G)

Table 24. Key Manufacturers Vancomycin Producing Area Distribution and Sales Area

Table 25. Players Vancomycin Products Offered

Table 26. Vancomycin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Vancomycin Sales by Geographic Region (2017-2022) & (KG)

Table 30. Global Vancomycin Sales Market Share Geographic Region (2017-2022)

Table 31. Global Vancomycin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Vancomycin Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Vancomycin Sales by Country/Region (2017-2022) & (KG)

Table 34. Global Vancomycin Sales Market Share by Country/Region (2017-2022)

Table 35. Global Vancomycin Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Vancomycin Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Vancomycin Sales by Country (2017-2022) & (KG)

Table 38. Americas Vancomycin Sales Market Share by Country (2017-2022)

Table 39. Americas Vancomycin Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Vancomycin Revenue Market Share by Country (2017-2022)

Table 41. Americas Vancomycin Sales by Type (2017-2022) & (KG)

Table 42. Americas Vancomycin Sales Market Share by Type (2017-2022)

Table 43. Americas Vancomycin Sales by Application (2017-2022) & (KG)

Table 44. Americas Vancomycin Sales Market Share by Application (2017-2022)

Table 45. APAC Vancomycin Sales by Region (2017-2022) & (KG)

Table 46. APAC Vancomycin Sales Market Share by Region (2017-2022)

Table 47. APAC Vancomycin Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Vancomycin Revenue Market Share by Region (2017-2022)

Table 49. APAC Vancomycin Sales by Type (2017-2022) & (KG)

Table 50. APAC Vancomycin Sales Market Share by Type (2017-2022)

Table 51. APAC Vancomycin Sales by Application (2017-2022) & (KG)

Table 52. APAC Vancomycin Sales Market Share by Application (2017-2022)

Table 53. Europe Vancomycin Sales by Country (2017-2022) & (KG)

Table 54. Europe Vancomycin Sales Market Share by Country (2017-2022)

Table 55. Europe Vancomycin Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Vancomycin Revenue Market Share by Country (2017-2022)

Table 57. Europe Vancomycin Sales by Type (2017-2022) & (KG)

Table 58. Europe Vancomycin Sales Market Share by Type (2017-2022)

Table 59. Europe Vancomycin Sales by Application (2017-2022) & (KG)

Table 60. Europe Vancomycin Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Vancomycin Sales by Country (2017-2022) & (KG)

Table 62. Middle East & Africa Vancomycin Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Vancomycin Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Vancomycin Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Vancomycin Sales by Type (2017-2022) & (KG)

Table 66. Middle East & Africa Vancomycin Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Vancomycin Sales by Application (2017-2022) & (KG)

Table 68. Middle East & Africa Vancomycin Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Vancomycin

Table 70. Key Market Challenges & Risks of Vancomycin

Table 71. Key Industry Trends of Vancomycin

Table 72. Vancomycin Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Vancomycin Distributors List

Table 75. Vancomycin Customer List

Table 76. Global Vancomycin Sales Forecast by Region (2023-2028) & (KG)

Table 77. Global Vancomycin Sales Market Forecast by Region

Table 78. Global Vancomycin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Vancomycin Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Vancomycin Sales Forecast by Country (2023-2028) & (KG)

Table 81. Americas Vancomycin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Vancomycin Sales Forecast by Region (2023-2028) & (KG)

Table 83. APAC Vancomycin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Vancomycin Sales Forecast by Country (2023-2028) & (KG)

Table 85. Europe Vancomycin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Vancomycin Sales Forecast by Country (2023-2028) & (KG)

Table 87. Middle East & Africa Vancomycin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Vancomycin Sales Forecast by Type (2023-2028) & (KG)

Table 89. Global Vancomycin Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Vancomycin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Vancomycin Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Vancomycin Sales Forecast by Application (2023-2028) & (KG)

Table 93. Global Vancomycin Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Vancomycin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Vancomycin Revenue Market Share Forecast by Application (2023-2028)

Table 96. Pfizer Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 97. Pfizer Vancomycin Product Offered

Table 98. Pfizer Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 99. Pfizer Main Business

Table 100. Pfizer Latest Developments

Table 101. Eli Lilly and Company Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 102. Eli Lilly and Company Vancomycin Product Offered

Table 103. Eli Lilly and Company Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 104. Eli Lilly and Company Main Business

Table 105. Eli Lilly and Company Latest Developments

Table 106. CJ CheilJedang Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 107. CJ CheilJedang Vancomycin Product Offered

Table 108. CJ CheilJedang Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 109. CJ CheilJedang Main Business

Table 110. CJ CheilJedang Latest Developments

Table 111. Xellia Pharmaceuticals ApS Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 112. Xellia Pharmaceuticals ApS Vancomycin Product Offered

Table 113. Xellia Pharmaceuticals ApS Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 114. Xellia Pharmaceuticals ApS Main Business

Table 115. Xellia Pharmaceuticals ApS Latest Developments

Table 116. VIANEX Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 117. VIANEX Vancomycin Product Offered

Table 118. VIANEX Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 119. VIANEX Main Business

Table 120. VIANEX Latest Developments

Table 121. Alchemia Limited Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 122. Alchemia Limited Vancomycin Product Offered

Table 123. Alchemia Limited Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 124. Alchemia Limited Main Business

Table 125. Alchemia Limited Latest Developments

Table 126. Alvogen Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 127. Alvogen Vancomycin Product Offered

Table 128. Alvogen Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 129. Alvogen Main Business

Table 130. Alvogen Latest Developments

Table 131. Aphios Corporation Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 132. Aphios Corporation Vancomycin Product Offered

Table 133. Aphios Corporation Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 134. Aphios Corporation Main Business

Table 135. Aphios Corporation Latest Developments

Table 136. Cellceutix Corporation Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 137. Cellceutix Corporation Vancomycin Product Offered

Table 138. Cellceutix Corporation Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 139. Cellceutix Corporation Main Business

Table 140. Cellceutix Corporation Latest Developments

Table 141. Enanta Pharmaceuticals Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 142. Enanta Pharmaceuticals Vancomycin Product Offered

Table 143. Enanta Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 144. Enanta Pharmaceuticals Main Business

Table 145. Enanta Pharmaceuticals Latest Developments

Table 146. Helix BioMedix Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 147. Helix BioMedix Vancomycin Product Offered

Table 148. Helix BioMedix Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 149. Helix BioMedix Main Business

Table 150. Helix BioMedix Latest Developments

Table 151. LegoChem Biosciences Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 152. LegoChem Biosciences Vancomycin Product Offered

Table 153. LegoChem Biosciences Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 154. LegoChem Biosciences Main Business

Table 155. LegoChem Biosciences Latest Developments

Table 156. Lytix Biopharma Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 157. Lytix Biopharma Vancomycin Product Offered

Table 158. Lytix Biopharma Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 159. Lytix Biopharma Main Business

Table 160. Lytix Biopharma Latest Developments

Table 161. MGB Biopharma Limited Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 162. MGB Biopharma Limited Vancomycin Product Offered

Table 163. MGB Biopharma Limited Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 164. MGB Biopharma Limited Main Business

Table 165. MGB Biopharma Limited Latest Developments

Table 166. Microbiotix. Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 167. Microbiotix. Vancomycin Product Offered

Table 168. Microbiotix. Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 169. Microbiotix. Main Business

Table 170. Microbiotix. Latest Developments

Table 171. MicuRx Pharmaceuticals Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 172. MicuRx Pharmaceuticals Vancomycin Product Offered

Table 173. MicuRx Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 174. MicuRx Pharmaceuticals Main Business

Table 175. MicuRx Pharmaceuticals Latest Developments

Table 176. Nabriva Therapeutics Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 177. Nabriva Therapeutics Vancomycin Product Offered

Table 178. Nabriva Therapeutics Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 179. Nabriva Therapeutics Main Business

Table 180. Nabriva Therapeutics Latest Developments

Table 181. NovaBay Pharmaceuticals Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 182. NovaBay Pharmaceuticals Vancomycin Product Offered

Table 183. NovaBay Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 184. NovaBay Pharmaceuticals Main Business

Table 185. NovaBay Pharmaceuticals Latest Developments

Table 186. NovoBiotic Pharmaceuticals Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 187. NovoBiotic Pharmaceuticals Vancomycin Product Offered

Table 188. NovoBiotic Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 189. NovoBiotic Pharmaceuticals Main Business

Table 190. NovoBiotic Pharmaceuticals Latest Developments

Table 191. Oragenics Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 192. Oragenics Vancomycin Product Offered

Table 193. Oragenics Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 194. Oragenics Main Business

Table 195. Oragenics Latest Developments

Table 196. Sealife Pharma Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 197. Sealife Pharma Vancomycin Product Offered

Table 198. Sealife Pharma Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 199. Sealife Pharma Main Business

Table 200. Sealife Pharma Latest Developments

Table 201. Taiwan Zhengde Pharmaceutical Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 202. Taiwan Zhengde Pharmaceutical Vancomycin Product Offered

Table 203. Taiwan Zhengde Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 204. Taiwan Zhengde Pharmaceutical Main Business

Table 205. Taiwan Zhengde Pharmaceutical Latest Developments

Table 206. Zhejiang Pharmaceutical Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 207. Zhejiang Pharmaceutical Vancomycin Product Offered

Table 208. Zhejiang Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 209. Zhejiang Pharmaceutical Main Business

Table 210. Zhejiang Pharmaceutical Latest Developments

Table 211. Zhejiang Haizheng Pharmaceutical Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 212. Zhejiang Haizheng Pharmaceutical Vancomycin Product Offered

Table 213. Zhejiang Haizheng Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 214. Zhejiang Haizheng Pharmaceutical Main Business

Table 215. Zhejiang Haizheng Pharmaceutical Latest Developments

Table 216. North China Pharmaceutical Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 217. North China Pharmaceutical Vancomycin Product Offered

Table 218. North China Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 219. North China Pharmaceutical Main Business

Table 220. North China Pharmaceutical Latest Developments

Table 221. Shenwei Pharmaceutical Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors

Table 222. Shenwei Pharmaceutical Vancomycin Product Offered

Table 223. Shenwei Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 224. Shenwei Pharmaceutical Main Business

Table 225. Shenwei Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Vancomycin

Figure 2. Vancomycin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vancomycin Sales Growth Rate 2017-2028 (KG)

Figure 7. Global Vancomycin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vancomycin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Daptomycin

Figure 10. Product Picture of Linezolid

Figure 11. Product Picture of Quinupristin

Figure 12. Product Picture of Ampicillin

Figure 13. Product Picture of Chloramphenicol

Figure 14. Product Picture of Others

Figure 15. Global Vancomycin Sales Market Share by Type in 2021

Figure 16. Global Vancomycin Revenue Market Share by Type (2017-2022)

Figure 17. Vancomycin Consumed in Sepsis

Figure 18. Global Vancomycin Market: Sepsis (2017-2022) & (KG)

Figure 19. Vancomycin Consumed in Lung Infection

Figure 20. Global Vancomycin Market: Lung Infection (2017-2022) & (KG)

Figure 21. Vancomycin Consumed in Skin Soft Tissue Infection

Figure 22. Global Vancomycin Market: Skin Soft Tissue Infection (2017-2022) & (KG)

Figure 23. Vancomycin Consumed in Colitis & Intestinal Inflammation

Figure 24. Global Vancomycin Market: Colitis & Intestinal Inflammation (2017-2022) & (KG)

Figure 25. Vancomycin Consumed in To Prevent Infection

Figure 26. Global Vancomycin Market: To Prevent Infection (2017-2022) & (KG)

Figure 27. Global Vancomycin Sales Market Share by Application (2017-2022)

Figure 28. Global Vancomycin Revenue Market Share by Application in 2021

Figure 29. Vancomycin Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Vancomycin Revenue Market Share by Company in 2021

Figure 31. Global Vancomycin Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Vancomycin Revenue Market Share by Geographic Region in 2021

Figure 33. Global Vancomycin Sales Market Share by Region (2017-2022)

Figure 34. Global Vancomycin Revenue Market Share by Country/Region in 2021

Figure 35. Americas Vancomycin Sales 2017-2022 (KG)

Figure 36. Americas Vancomycin Revenue 2017-2022 ($ Millions)

Figure 37. APAC Vancomycin Sales 2017-2022 (KG)

Figure 38. APAC Vancomycin Revenue 2017-2022 ($ Millions)

Figure 39. Europe Vancomycin Sales 2017-2022 (KG)

Figure 40. Europe Vancomycin Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Vancomycin Sales 2017-2022 (KG)

Figure 42. Middle East & Africa Vancomycin Revenue 2017-2022 ($ Millions)

Figure 43. Americas Vancomycin Sales Market Share by Country in 2021

Figure 44. Americas Vancomycin Revenue Market Share by Country in 2021

Figure 45. United States Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Vancomycin Sales Market Share by Region in 2021

Figure 50. APAC Vancomycin Revenue Market Share by Regions in 2021

Figure 51. China Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Vancomycin Sales Market Share by Country in 2021

Figure 58. Europe Vancomycin Revenue Market Share by Country in 2021

Figure 59. Germany Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Vancomycin Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Vancomycin Revenue Market Share by Country in 2021

Figure 66. Egypt Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Vancomycin Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Vancomycin in 2021

Figure 72. Manufacturing Process Analysis of Vancomycin

Figure 73. Industry Chain Structure of Vancomycin

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390